FIELD: chemistry.
SUBSTANCE: group of inventions refers to the chemical-pharmaceutical industry and is a hemostatic solution, containing an aqueous base and an active substance, which is a sulfated kappa-carrageenan polysaccharide in a volume per 1 liter of an aqueous solution of 0.1–3.0 wt%, and a hemostatic sponge based on it. Group of inventions also includes a method of obtaining a hemostatic solution and a hemostatic sponge based on it.
EFFECT: group of inventions allows to expand the assortment of hemostatic means with pronounced hemostatic action, which can be used for the bleed prevention in surgical practice, in combat situations, in the aftermath of mass disasters and terrorist acts, as well as in conditions of hostilities.
9 cl, 27 ex
Title | Year | Author | Number |
---|---|---|---|
HEMOSTATIC SPONGE AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2628809C1 |
HAEMOSTATIC SPONGE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2618896C1 |
HEMOSTATIC SPONGE (VERSIONS) | 2016 |
|
RU2627855C1 |
HAEMOSTATIC AGENT BASED ON POLYVINYLPYRROLIDONE AND METHODS FOR PREPARING ITS PHARMACOLOGICAL FORMS | 2018 |
|
RU2705812C1 |
HEMOSTATIC COATING IN FORM OF SPONGE OR FILM (VERSIONS) | 2016 |
|
RU2639379C1 |
HEMOSTATIC COATING IN THE FORM OF POWDER | 2017 |
|
RU2660582C1 |
WOUND COVER WITH HEMOSTATIC ACTION, AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2624242C1 |
HAEMOSTATIC POLYMER-BASED AGENT CONTAINING MICROPARTICLES AND IRON OXIDE NANOPARTICLES, AND METHODS FOR PREPARING PHARMACOLOGICAL FORMS THEREOF | 2020 |
|
RU2739490C1 |
HEMOSTATIC GLUE | 2004 |
|
RU2270015C1 |
HEMOSTATIC GLUE | 2004 |
|
RU2262937C1 |
Authors
Dates
2018-04-25—Published
2017-05-24—Filed